Ribosomal protein L17 pseudogene 27 (RPL17P27)

Ribosomal protein L17 pseudogene 27 (RPL17P27) is classified as a processed pseudogene, which means it is a non-functional genomic DNA sequence similar to a functional ribosomal protein gene (RPL17), but it does not encode a functional protein product. Pseudogenes like RPL17P27 are believed to arise from gene duplication or retrotransposition events. While conservation of some pseudogenes suggests potential regulatory roles in rare cases, there is no evidence that RPL17P27 produces a protein or serves as a direct therapeutic target[1][2][5][8]. RPL17 (the functional gene) encodes a structural protein of the 60S ribosomal subunit, but RPL17P27 is not known to have any direct biological, therapeutic, or disease role. Therefore, RPL17P27 is not considered a drug target, receptor, or enzyme, and there are no known drugs, mechanisms of action, or disease associations linked to this pseudogene[1][8]. #### Key points for structured data extraction: - RPL17P27 is a pseudogene (not coding for a functional protein). - Not a biologically active target nor a therapeutic target. - No associated drugs or clinical uses. - Mark as is_incorrect: true due to being a pseudogene, not a standard "target" in pharmacological or molecular sense.

Other names

RPL17_17_857RPL17P27